Discover
NVCR
NovoCure Limited
15.78
2 x 11.40
2 x 19.68
bid
ask
+
0.63
4.16%
2 @ 04:00 PM
15.88 +0.10 (0.66%)
| Ytd | 22.04% | |
| 1y | -11.74% |
15.29
day range
16.00
9.82
52 week range
18.92
| Open | 15.29 | Prev Close | 15.15 | Low | 15.29 | High | 16.00 | Mkt Cap | 1.83B |
| Vol | 1.20M | Avg Vol | 1.64M | EPS | -1.53 | P/E | N/A | Forward P/E | -12.70 |
| Beta | 0.92 | Short Ratio | 6.44 | Inst. Own | 88.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-23 | 50-d Avg | 16.14 | 200-d Avg | 13.46 | 1yr Est | 26.00 |
| Income Statement | |||
| Total Revenue | 174.06M | ||
| Revenues (USD) | 174.06M | ||
| Cost of Revenue | 38.93M | ||
| Gross Profit | 135.13M | ||
| Operating Expenses | 202.55M | ||
| Research and Development Expense | 58.34M | ||
| Selling, General and Administrative Expense | 144.21M | ||
| Operating Income | -67.42M | ||
| Interest Expense | 1.84M | ||
| Income Tax Expense | 1.88M | ||
| Net Income | -71.14M | ||
| Net Income Common Stock | -71.14M | ||
| Net Income Common Stock (USD) | -71.14M | ||
| Consolidated Income | -71.14M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -67.42M | ||
| Earning Before Interest & Taxes (USD) | -67.42M | ||
| Weighted Average Shares | 114.15M | ||
| Weighted Average Shares Diluted | 114.15M | ||
| Balance Sheet | |||
| Cash and Equivalents | 97.32M | ||
| Cash and Equivalents (USD) | 97.32M | ||
| Investments | 344.48M | ||
| Investments Current | 344.48M | ||
| Trade and Non-Trade Receivables | 146.40M | ||
| Current Assets | 631.66M | ||
| Property, Plant & Equipment Net | 145.06M | ||
| Total Assets | 787.93M | ||
| Total Debt | 234.94M | ||
| Current Liabilities | 217.58M | ||
| Debt Non-Current | 234.94M | ||
| Total Liabilities | 457.21M | ||
| Accumulated Retained Earnings (Deficit) | -1.36B | ||
| Accumulated Other Comprehensive Income | -4.89M | ||
| Shareholders Equity | 330.72M | ||
| Shareholders Equity (USD) | 330.72M | ||
| Assets Non-Current | 156.26M | ||
| Total Debt (USD) | 234.94M | ||
| Inventory | 43.46M | ||
| Liabilities Non-Current | 239.63M | ||
| Trade and Non-Trade Payables | 127.24M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.12M | ||
| Net Cash Flow from Financing | -166.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.07M | ||
| Capital Expenditure | -5.15M | ||
| Net Cash Flow from Investing | 7.75M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.90M | ||
| Net Cash Flow from Operations | -13.52M | ||
| Effect of Exchange Rate Changes on Cash | -130.00K | ||
| Share Based Compensation | 63.01M | ||